摘要
目的分析2015年重症监护病房(ICU)多重耐药鲍曼不动杆菌(MDR-AB)的检出情况与耐药性,为ICU的MDR-AB医院感染防控及抗菌药物选用提供科学依据。方法回顾性分析2015年度本院ICU MDR-AB的检出情况与耐药率资料。结果 2015年ICU检出MDR-AB共153株,占全院MDR-AB的56.3%,主要在痰标本中检出,对常用抗菌药物普遍耐药,对米诺环素耐药率24.5%。结论 MDR-AB对常用抗菌药物耐药情况严重,应通过加强抗菌药物合理使用、加强手卫生和消毒隔离来防控。
Objective Analyze the detection and bacterial drug resistance of MDR-AB in ICU in 2015 for the scientific basis of prevention and control of MDR-AB hospital infection in ICU. Methods Retrospective analyze the detection and drug resistance of MDR-AB in ICU in 2015. Results 153 strains of MDR-AB was detected in ICU in 2015, accounting for 56.3%. MDR-AB mainly distributed in sputum samples and generally resistant to commonly used antimicrobial agents and the resistance rate of minocycline is 24.5%. Conclusion Drug resistance situation of MDR-AB is grim. In order to prevent and control MDR-AB, the rational use of antibiotics and the hand hygiene and disinfection and isolation should be strengthen.
出处
《疾病监测与控制》
2016年第12期970-971,共2页
Journal of Diseases Monitor and Control
基金
广东省科学技术厅项目[2012B031800241]
